Qiagen N.V. - stock earnings

QGEN Upcoming estimated earnings

Date Actual / Estimated EPS Low Revenue Actual / Estimated Revenue High Revenue
April 29, 2024 AfterMarket 0.46 / 0.45 - - / 466.5 million -

QGEN Quarterly earnings

DateEarningsRevenue
2023Q4 97.7 million USD 509.2 million USD
2023Q3 77.8 million USD 475.9 million USD
2023Q2 80.8 million USD 494.9 million USD
2023Q1 85.0 million USD 485.4 million USD
2022Q4 88.8 million USD 498.0 million USD
2022Q3 82.4 million USD 499.6 million USD
2022Q2 96.7 million USD 515.5 million USD
2022Q1 155.3 million USD 628.4 million USD
2021Q4 129.2 million USD 582.4 million USD
2021Q3 133.1 million USD 534.7 million USD
2021Q2 121.1 million USD 567.3 million USD
2021Q1 129.2 million USD 567.2 million USD
2020Q4 212.7 million USD 571.2 million USD
2020Q3 16.9 million USD 483.8 million USD
2020Q2 89.8 million USD 443.3 million USD
2020Q1 39.8 million USD 372.1 million USD
2019Q4 44.9 million USD 413.5 million USD
2019Q3 -160.6 million USD 382.7 million USD
2019Q2 44.7 million USD 381.6 million USD
2019Q1 29.5 million USD 348.7 million USD
2018Q4 61.0 million USD 403.2 million USD
2018Q3 60.3 million USD 377.9 million USD
2018Q2 36.8 million USD 377.2 million USD
2018Q1 32.3 million USD 343.6 million USD
2017Q4 -39.7 million USD 396.9 million USD
2017Q3 48.5 million USD 364.0 million USD
2017Q2 14.0 million USD 349.0 million USD
2017Q1 17.7 million USD 307.7 million USD
2016Q4 8.6 million USD 366.5 million USD
2016Q3 33.8 million USD 338.7 million USD
2016Q2 21.0 million USD 334.4 million USD
2016Q1 14.9 million USD 298.4 million USD
2015Q4 48.6 million USD 348.5 million USD
2015Q3 33.9 million USD 314.6 million USD
2015Q2 25.1 million USD 319.5 million USD
2015Q1 19.5 million USD 298.4 million USD
2014Q4 25.8 million USD 360.4 million USD
2014Q3 34.7 million USD 336.5 million USD
2014Q2 32.8 million USD 330.8 million USD
2014Q1 23.3 million USD 317.1 million USD
2013Q4 60.2 million USD 361.1 million USD
2013Q3 40.7 million USD 322.1 million USD
2013Q2 -51.8 million USD 315.2 million USD
2013Q1 20.0 million USD 303.6 million USD
2012Q4 38.4 million USD 346.5 million USD
2012Q3 29.2 million USD 304.3 million USD
2012Q2 33.3 million USD 307.2 million USD
2012Q1 28.6 million USD 296.4 million USD
2011Q4 -376000 USD 334.4 million USD
2011Q3 35.1 million USD 288.9 million USD
2011Q2 33.3 million USD 282.2 million USD
2011Q1 28.0 million USD 264.3 million USD
2010Q4 36.3 million USD 286.0 million USD
2010Q3 36.5 million USD 274.3 million USD
2010Q2 38.5 million USD 262.7 million USD
2010Q1 33.0 million USD 264.4 million USD
2009Q4 44.5 million USD 289.1 million USD
2009Q3 37.7 million USD 259.7 million USD
2009Q2 30.9 million USD 240.2 million USD
2009Q1 24.7 million USD 220.9 million USD
2008Q4 24.7 million USD 237.2 million USD
2008Q3 20.8 million USD 230.8 million USD
2008Q2 23.2 million USD 217.9 million USD
2008Q1 20.3 million USD 207.1 million USD
2007Q4 15.0 million USD 210.2 million USD
2007Q3 -7.3 million USD 176.6 million USD
2007Q2 22.6 million USD 135.0 million USD
2007Q1 19.4 million USD 125.9 million USD
2006Q4 19.4 million USD 125.9 million USD
2006Q3 19.4 million USD 117.9 million USD
2006Q2 14.2 million USD 113.2 million USD
2006Q1 16.9 million USD 104.3 million USD
2005Q4 16.9 million USD 104.3 million USD
2005Q3 17.6 million USD 98.7 million USD
2005Q2 13.8 million USD 100.4 million USD
2005Q1 15.8 million USD 95.5 million USD
2004Q4 15.8 million USD 95.5 million USD
2004Q3 12.6 million USD 90.4 million USD
2004Q2 8.8 million USD 98.6 million USD
2004Q1 11.4 million USD 96.1 million USD
2003Q4 9.0 million USD 95.1 million USD
2003Q3 11.8 million USD 90.4 million USD
2003Q2 11.1 million USD 86.3 million USD
2003Q1 11.0 million USD 79.6 million USD
2002Q4 1.8 million USD 78.4 million USD
2002Q3 7.3 million USD 76.9 million USD
2002Q2 4.6 million USD 72.7 million USD
2002Q1 10.9 million USD 71.2 million USD
2001Q4 10.9 million USD 71.2 million USD
2001Q3 6.2 million USD 63.3 million USD
2001Q2 11.3 million USD 66.0 million USD
2001Q1 6.0 million USD 63.1 million USD
2000Q4 6.6 million USD 56.7 million USD
2000Q3 6.5 million USD 50.5 million USD
2000Q2 1.4 million USD 49.8 million USD
2000Q1 5.2 million USD 42.2 million USD
1999Q4 358000 USD 39.1 million USD
1999Q3 4.5 million USD 35.6 million USD
1999Q2 4.0 million USD 35.2 million USD
1999Q1 3.8 million USD 34.0 million USD
1998Q4 3.7 million USD 30.1 million USD
1998Q3 3.2 million USD 28.3 million USD
1998Q2 2.9 million USD 26.2 million USD
1998Q1 2.9 million USD 24.0 million USD
1997Q4 2.9 million USD 20.3 million USD
1997Q3 2.0 million USD 19.0 million USD
1997Q2 1.9 million USD 17.9 million USD
1997Q1 2.0 million USD 17.1 million USD
1996Q4 1.8 million USD 15.0 million USD
1996Q3 1.5 million USD 14.2 million USD
1996Q2 1.1 million USD 12.6 million USD
1996Q1 1.0 million USD 12.5 million USD

QGEN Yearly earnings

DateEarningsRevenue
2023 341.3 million USD 2.0 billion USD
2022 423.2 million USD 2.1 billion USD
2021 512.6 million USD 2.3 billion USD
2020 73.6 million USD 1.9 billion USD
2019 -41.5 million USD 1.5 billion USD
2018 190.4 million USD 1.5 billion USD
2017 40.4 million USD 1.4 billion USD
2016 80.4 million USD 1.3 billion USD
2015 127.1 million USD 1.3 billion USD
2014 116.6 million USD 1.3 billion USD
2013 69.1 million USD 1.3 billion USD
2012 129.5 million USD 1.3 billion USD
2011 96.0 million USD 1.2 billion USD
2010 144.3 million USD 1.1 billion USD
2009 137.8 million USD 1.0 billion USD
2008 89.0 million USD 893.0 million USD
2007 50.1 million USD 649.8 million USD
2006 70.5 million USD 465.8 million USD
2005 62.2 million USD 398.4 million USD
2004 48.7 million USD 380.6 million USD
2003 42.9 million USD 351.4 million USD
2002 23.1 million USD 298.6 million USD
2001 34.4 million USD 263.8 million USD
2000 20.1 million USD 204.0 million USD
1999 12.6 million USD 144.0 million USD
1998 12.4 million USD 110.2 million USD
1997 8.8 million USD 74.3 million USD
1996 5.3 million USD 54.2 million USD
1995 2.4 million USD 37.0 million USD

QGEN

Price: $42.30

52 week price:
34.74
47.70

5-year range yield:
3.02%
3.02%

Forward Dividend Yield: 3.17%

Payout Ratio: 86.25%

Payout Ratio Range:
-799.27%
2012.55%

Dividend Per Share: 1.32 USD

Earnings Per Share: 1.53 USD

P/E Ratio: 29.08

Exchange: NYQ

Sector: Healthcare

Industry: Diagnostics & Research

Volume: 670300

Ebitda: 103.6 million

Market Capitalization: 9.2 billion

Average Dividend Frequency: 1

Years Paying Dividends: 1

Links: